• Parkinson’s Research

  Once-a-day Option for Patients with Parkinson’s Who Experience Psychosis

  Posted by Forum Moderator on July 7, 2018 at 6:46 am

  The FDA has approved a once-a-day capsule formulation of Nuplazid — instead of twice-daily current formulation of this treatment for Parkinson’s psychosis — and a new lower-strength tablet for select patients also taking cytochrome 3A4 inhibitors.

  Click here to read a summary of this news: Once-a-day Capsule for Nuplazid and Lower Dose Option Approved for Parkinson’s Psychosis Patients

  What are your thoughts on this news? Is this new treatment an option for you?

  replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply